DEF 14AThe Ballot
Damora Therapeutics, Inc. files DEF 14A
Filed Apr 29, 2024 · 2y ago · Accession 0000950170-24-049811
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- DEF 14A
- Filing date
- Apr 29, 2024
- Report date
- Jun 20, 2024
- Document
- glto-2024-def_14a_v2.htm
- Size
- 1.8 MB